Tag Archives: National Institutes for Health

NIH Director Speaks Out on the Institutes' New Remit

As the National Institutes for Health hits the headlines over its remit to help develop new medicines, Director Francis Collins talks to Pharm Exec about the new initiatives he sees as critical for innovation, industry and public health. Francis Collins devoted more than 15 years in the lab to deciphering the human genome. Ten years […]
Posted in FDA, Gene therapy, Guest Blog, healthcare, IP, leadership, R&D, Regulatory | Also tagged , , , , , | 1 Comment
  • Categories

  • Meta